Latest News and Press Releases

The Chairman Hans Peter Bøhn has today, 19 September 2018, subscribed for 40,106 new shares in PCI Biotech Holding ASA (the "Company") at a subscription price of NOK 30 per share by exercising all his...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR...

Oslo, 13 September 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and...

Oslo (Norway), 30 August 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim second quarter and first half-year 2018 result. Please find enclosed the...

Date on which the terms and conditions of the preferential rights issue were announced:  24 august 2018Last day including right: 14 September 2018Ex-date: 17 September 2018Record Date: 18 September...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH...

Oslo, 23 August 2018 - PCI Biotech invites to a presentation of the company's second quarter and first half year 2018 report on Thursday 30 August 2018 at Oslo Cancer Cluster Innovation Park. Time:...